$0.693
-0.072 (-10.36%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
MIST-Prognose durch Analyse ähnlicher Charts
Alphio's MIST stock price prediction model matches the current Milestone Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.69 (-0.13%). The 1-week path is $0.66 (-4.00%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Milestone Pharmaceuticals Inc-Aktien kaufen?
Milestone Pharmaceuticals Inc is a good buy right now due to its recent approval for etripamil in China, which triggered a $2 million milestone payment and opens up a significant market opportunity. The current price is $0.7268, and analysts project a price target of $3, suggesting a potential upside of approximately 313%. Additionally, the stock has shown a 5-day change of +12.79%, indicating positive momentum. However, the main risk is the company's substantial net losses, with a net income of -$28,614,000 in Q2 2026.
MIST schloss am Thursday bei $0.69, nachdem der Kurs -10.36% fallen
Milestone Pharmaceuticals Inc (MIST) last closed at $0.6925, losing -10.36%. These facts feed the 1-day and 1-week MIST price prediction above.
Prognose-Treiber
Die Prognose-Treiber von Milestone Pharmaceuticals Inc (MIST) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf MIST am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für MIST
Historically the probability of a positive November return for MIST is 51.16%. December offers the highest probability of a positive month at 65.12%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-Jahres-Kursprojektionen für MIST
| Monat | Tiefstkurs | Ø-Kurs | Höchstkurs | Potenzieller ROI |
|---|---|---|---|---|
| Nov 2026 | $1.71 | $1.91 | $2.16 | +175.50% |
| Dec 2026 | $1.71 | $1.89 | $2.13 | +172.59% |
Für 2026 wird für Milestone Pharmaceuticals Inc (MIST) eine Spanne von $1.71 bis $2.16 projiziert.
Monatsprognose 2026 für Milestone Pharmaceuticals Inc
Im Nov 2026 wird für Milestone Pharmaceuticals Inc ein Durchschnitt von $1.91 erwartet, mit einem Tief von $1.71 und einem Hoch von $2.16.
Im Dec 2026 wird für Milestone Pharmaceuticals Inc ein Durchschnitt von $1.89 erwartet, mit einem Tief von $1.71 und einem Hoch von $2.13.
Ähnliche Artikel
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.